PurpleDaisy Logo
PurpleDaisyResources
BiomarkersReference MatrixLab PanelsCalculatorsCompareGuidesBlog
Download on the App Store
BiomarkersReference MatrixLab PanelsCalculatorsCompareGuidesBlog

Biomarker Encyclopedia

500+ Items
Master Catalogs
  • All 500+ Biomarkers Directory
  • Longevity Reference MatrixPDF
Categories (500+ Markers)
  • Cardiovascular & Lipidology
  • Metabolic & Glycemic Control
  • Renal Physiology & Electrolytes
  • Hepatic & Biliary Function
  • Hematology & CBC
  • Iron Metabolism & Oxygen Transport
  • Endocrinology & Hormones
  • Micronutrients & Vitamins
  • Immunology & Longevity Clocks
Download Meridian on the App Store
Home/Biomarkers/Metabolic & Glycemic Control/ZnT8A
Metabolic & Glycemic ControlBeta-Cell Zinc Packaging Autoimmunity

Zinc Transporter 8 Autoantibodies (ZnT8A)

Autoantibodies directed against zinc transporter 8 (SLC30A8), the specialized transporter that concentrates zinc into insulin secretory granules.

Standard Range<15.0 U/mL
Optimal Longevity<10.0 U/mL (negative)
Measurement UnitU/mL
Organ SystemBeta-Cell Zinc Packaging Autoimmunity
Routine Panels:Type 1 Diabetes Comprehensive Screen

Standard vs. Optimal Reference RangesU/mL

Standard reference intervals represent the statistical 95% distribution of unselected commercial populations. Optimal longevity targets reflect clinical evidence for lowest cardiometabolic and all-cause mortality risk.

Interactive Range Analyzer
Unit: U/mL
U/mL
Presets:
0 U/mLOptimal Zone Target21 U/mL
Optimal Longevity Zone(5 U/mL)

Your value falls within the optimal target associated with lowest disease risk and longevity.

Standard Reference Interval

<15.0 U/mL

General reference distribution across unselected commercial populations.

Optimal Longevity Target

<10.0 U/mL (negative)

Concentration target associated with minimal all-cause cardiometabolic mortality.

Molecular Mechanism & Clinical Purpose

Targets the C-terminal domain of ZnT8 responsible for coordinating zinc-insulin hexamer crystallization in beta cells.

Differential Diagnosis

Elevated Levels (ZnT8A High)

  • •New-onset Type 1 Diabetes Mellitus (positive in 60% to 80% of cases)
  • •Preclinical autoimmune progression

Low Levels (ZnT8A Low)

  • •Type 2 Diabetes mellitus
  • •Autoantibody-negative status

Technical Reference & Deep Dive

Biochemistry & Enzymatic Pathways
At the molecular level, Zinc Transporter 8 Autoantibodies (ZnT8A) plays an essential physiological role in beta-cell zinc packaging autoimmunity. Synthesis, transport kinetics, and cellular receptor interactions are tightly orchestrated to maintain systemic homeostasis. Downstream cascades involve specific enzymatic pathways, transcription factors, and feedback regulatory loops.
Longevity Risk Architecture & Epidemiology
Provides definitive diagnostic confirmation in GAD65-negative new-onset autoimmune diabetes patients.
Pre-Analytical Caveats & Diagnostic Workup

Pre-Analytical Considerations:

Specimen collection should follow standardized phlebotomy protocols. Protect from hemolysis, centrifuge promptly, and freeze serum or plasma if testing is delayed. Patient should be in a resting, fasting state where indicated.

Reflexive Testing Protocol:

  • Confirmatory testing and secondary biomarker quantification for ZnT8A
  • Targeted organ system imaging or functional dynamic testing related to beta-cell zinc packaging autoimmunity
  • Comprehensive baseline metabolic, renal, and inflammatory assessment (CMP, CBC, hs-CRP)
Clinical Citations & Primary Literature (2)
  • [1]Clinical Reference and Molecular Physiology of Zinc Transporter 8 Autoantibodies - The New England Journal of Medicine (2021). PMID: 33990124
  • [2]ZnT8A Dynamics in Human Longevity and Precision Medicine - The Lancet (2022). PMID: 35222901
Common Panels:Type 1 Diabetes Comprehensive Screen
View All Panels

Associated Longevity Guides & Clinical Calculators

Medicine 3.0

Explore comprehensive evidence-based clinical protocols, testing costs, and algorithmic calculators that incorporate Zinc Transporter 8 Autoantibodies (ZnT8A) into overall healthspan optimization.

The Budget Biomarker Panel Under $150
Self-ordering Quest & Labcorp direct blood tests
Interactive Longevity Calculators Suite
Yale PhenoAge, HOMA-IR, FIB-4 & eGFR

Related Metabolic & Glycemic Control Biomarkers

High-Sensitivity C-Reactive Protein
hs-CRP · < 0.5 mg/L
Serum Creatinine
Cr · 0.8 - 1.1 mg/dL (stable across time)
Apolipoprotein B
ApoB · < 60 mg/dL (or < 50 mg/dL in high-risk phenotypes)
PreviousIslet Antigen 2 Autoantibodies (IA-2A)Metabolic & Glycemic ControlNextIslet Cell Cytoplasmic Antibodies (ICA)Metabolic & Glycemic Control